Drugs / Clarithromycin
last change 3 days ago re-read 2 minutes ago

Clarithromycin

also known as Biaxin · Klacid · klaricid · CAM · CLA · CLM · 6-o-methylerythromycin · A-56268 · +37 more

Small molecule targets BCL2, CYP3A4 via inhibition

Developed for
Helicobacter pylori infectious disease · plasma cell myeloma · HIV infectious disease · Mycobacterium avium complex disease · dyspepsia · gastritis · peptic ulcer disease · gastric cancer
+72 more · lymphoma · pulmonary non-tuberculous mycobacterial infection · autoimmune thrombocytopenic purpura · chronic rhinosinusitis · Crohn disease · gastric ulcer · multidrug-resistant tuberculosis · asthma · Buruli ulcer disease · chronic gastritis · COVID-19 · duodenal ulcer · gastric mucosa-associated lymphoid tissue lymphoma · idiopathic hypersomnia · neoplasm · pneumonia · refractory plasma cell neoplasm · bacterial gastritis · bronchiectasis · bronchitis · cerebral toxoplasmosis · cervical incompetence · chronic lymphocytic leukemia/small lymphocytic lymphoma · cystic fibrosis · drug allergy · gastric diffuse large B-cell lymphoma · gastric neoplasm · gastroesophageal reflux disease · granulomatous mastitis · heart disorder · infectious disease · infectious disease with sepsis · influenza · irritable bowel syndrome · lung disorder · MALT lymphoma · narcolepsy without cataplexy · narcolepsy-cataplexy syndrome · non-Hodgkin lymphoma · non-small cell lung carcinoma · non-transplant-related bronchiolitis obliterans · otitis media · periodontitis · periodontitis, aggressive · pharyngitis · preterm premature rupture of the membranes · pseudomyxoma peritonei · relapsing-remitting multiple sclerosis · squamous cell lung carcinoma · stomach polyp · tonsillitis · ulcerative colitis · Ureaplasma urethritis · active peptic ulcer disease · acute respiratory distress syndrome · autoimmune thrombocytopenia · bacterial pneumonia · Borrelia infectious disease · bronchopulmonary dysplasia · chronic bronchitis · gram-negative bacterial infections · HIV wasting syndrome · lung cancer · Lyme disease · membranous glomerulonephritis · multiple organ dysfunction syndrome · nephrotic syndrome · primary bacterial infectious disease · respiratory tract infectious disorder · sinusitis · staphylococcus aureus infection · ulcer disease
Investigated by
National Taiwan University Hospital · Abbott · National Institute of Allergy and Infectious Diseases (NIAID) · Shandong University · Weill Medical College of Cornell University · Celgene Corporation
+314 more · Kaohsiung Veterans General Hospital. · National Cancer Institute (NCI) · Seoul National University Hospital · Kaohsiung Medical University · Pfizer · RedHill Biopharma Limited · Teva Pharmaceuticals USA · Eli Lilly and Company · Janssen Research & Development, LLC · Mackay Memorial Hospital · Shanghai Jiao Tong University School of Medicine · Shanghai Zhongshan Hospital · Takeda · University Medical Center Groningen · Alexandria University · Assistance Publique - Hôpitaux de Paris · Baqiyatallah Medical Sciences University · Beijing Children's Hospital · Boehringer Ingelheim · Buddhist Tzu Chi General Hospital · Chang Gung Memorial Hospital · Changhua Christian Hospital · China Medical University Hospital · Danish Myeloma Study Group · Fred Hutchinson Cancer Center · Hamamatsu University · Henrik Gregersen · Heze Municipal 3rd people's hospital · IRCCS Azienda Ospedaliero-Universitaria di Bologna · Kyungpook National University Hospital · Liaocheng People's Hospital · Maternity and Child Care Health Center of Dezhou · National Health Research Institutes, Taiwan · Peking University Care Luzhong Hospital · Phathom Pharmaceuticals, Inc. · Samsung Medical Center · Sandoz · Second Affiliated Hospital of Xi'an Jiaotong University · Second Affiliated Hospital, School of Medicine, Zhejiang University · Sun Yat-sen University · Tanta University · The First Affiliated Hospital with Nanjing Medical University · The University of Hong Kong · The University of Queensland · The University of Texas Health Science Center at Tyler · Xijing Hospital of Digestive Diseases · Abdul Wali Khan University Mardan · Academic Histology Laboratory (Latvia) · Academy Military Medical Science, China · Aché Laboratórios Farmacêuticos Ltda · Affiliated Hospital of Jiangnan University · Aga Khan University · Ajou University School of Medicine · Akil Al Islam · All India Institute of Medical Sciences, Bhubaneswar · American University of Beirut Medical Center · Anderson Clinical Research · Andres J. M. Ferreri · Antios Therapeutics, Inc · Antonio Mestrovic · Asan Medical Center · Assiut University · Australian Government Department of Health and Ageing · Australian and New Zealand Intensive Care Research Centre · Ayman Magd Eldin Mohammad Sadek · Azfar Farogh · Baylor College of Medicine · BeiGene · Beijing Chest Hospital · Berry Consultants · Bill and Melinda Gates Foundation · Binzhou People's Hospital · Bristol-Myers Squibb · British Thoracic Society · all 320 on the full record

Regulatory milestones approvals, filings & regulatory actions · 11 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansions (2) US (FDA) BIAXIN XL 2001-08-02 – 2002-05-24 fda.gov
Label expansions (8) US (FDA) BIAXIN 1994-08-12 – 2000-10-20 fda.gov
Approved US (FDA) BIAXIN 1991-10-31 fda.gov

Trials 257 · started per year

today
US approved 1991
2
1
1
4
2
2
2
3
2
2
8
5
4
1
7
7
3
6
10
10
10
13
10
13
13
18
16
11
11
14
13
7
5
6
7
1
1990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT04525664 Oct 2018 → May 2019 Helicobacter pylori infectious disease, dyspepsia Washington University School of Medicine Completed No outcome recorded
Phase 152 trials
Phase 1 NCT07696091 Jul → Sep 2026 expected chronic obstructive pulmonary disease, chronic rhinosinusitis Reistone Biopharma Company Limited Not yet recruiting No outcome recorded
Phase 1 NCT07040787 Jul → Aug 2025 glomerulonephritis, hemolytic anemia Chengdu Suncadia Medicine Co., Ltd. Completed No outcome recorded
Phase 1 NCT06837259 Mar → Jun 2025 Pfizer Completed No outcome recorded
Phase 1 NCT06551623 Aug → Oct 2024 Helicobacter pylori infectious disease TenNor Therapeutics Limited Completed No outcome recorded
Phase 1 NCT06227832 Dec 2023 → Mar 2024 Kaken Pharmaceutical Completed No outcome recorded
Phase 1 NCT05991401 Aug → Nov 2023 Dong-A ST Co., Ltd. Completed No outcome recorded
Phase 1 NCT06005714 Aug → Oct 2023 Shanghai Vinnerna Biosciences Co., Ltd. Completed No outcome recorded
Phase 1 NCT05965570 Jul → Sep 2023 Insmed Incorporated Completed No outcome recorded
Phase 1 NCT05915871 Mar → Apr 2023 Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. Completed No outcome recorded
Phase 1 NCT05633147 Nov 2022 → May 2023 Cinclus Pharma Holding AB Completed No outcome recorded
Phase 1/22 trials
Phase 1/2 NCT07454772 Mar 2026 → Apr 2027 expected granulomatous mastitis All India Institute of Medical Sciences, Bhubaneswar Not yet recruiting No outcome recorded
Phase 1/2 NCT02542657 Oct 2015 → Aug 2025 overdue plasma cell myeloma Joseph Tuscano Active not recruiting No outcome recorded
Phase 243 trials
Phase 2 NCT07485010 Apr 2027 → Apr 2031 expected pulmonary non-tuberculous mycobacterial infection The University of Queensland Not yet recruiting No outcome recorded
Phase 2 NCT07341100 Jan 2026 → Jan 2028 expected malignant epithelial tumor of ovary Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Active not recruiting No outcome recorded
Phase 2 NCT07144657 Sep 2025 → Dec 2029 expected gastric mucosa-associated lymphoid tissue lymphoma National Taiwan University Hospital Not yet recruiting No outcome recorded
Phase 2 NCT06510010 Dec 2024 → Dec 2026 expected chemotherapy-induced toxicity Sixth Affiliated Hospital, Sun Yat-sen University Recruiting No outcome recorded
Phase 2 NCT04843579 Dec 2021 → Nov 2022 plasma cell myeloma Weill Medical College of Cornell University Terminated No outcome recorded
Phase 2 NCT04302324 Oct 2021 → May 2024 overdue plasma cell myeloma, refractory plasma cell neoplasm Weill Medical College of Cornell University Active not recruiting No outcome recorded
Phase 2 NCT04398004 May → Nov 2020 COVID-19 Hellenic Institute for the Study of Sepsis Completed No outcome recorded
Phase 2 NCT04026958 Sep 2019 → Jun 2025 idiopathic hypersomnia, narcolepsy without cataplexy, narcolepsy-cataplexy syndrome Emory University Completed No outcome recorded
Phase 2 NCT03935828 Jun 2019 → Dec 2020 chronic rhinosinusitis, poisoning United States Naval Medical Center, San Diego Withdrawn No outcome recorded
Phase 2 NCT03428568 Mar 2018 → Mar 2019 dyspepsia, gastritis King Abdullah International Medical Research Center Unknown No outcome recorded
Phase 2/37 trials
Phase 2/3 NCT05297695 Apr 2022 → Oct 2023 Helicobacter pylori infectious disease, generalized epilepsy Sohag University Completed No outcome recorded
Phase 2/3 NCT04310930 Mar 2020 → Jun 2029 expected pulmonary non-tuberculous mycobacterial infection The University of Queensland Recruiting No outcome recorded
Phase 2/3 NCT02969928 Mar 2015 → Dec 2016 periodontitis, aggressive São Paulo State University Completed No outcome recorded
Phase 2/3 NCT01659437 Dec 2012 → Dec 2017 Buruli ulcer disease University Medical Center Groningen Completed No outcome recorded
Phase 2/3 NCT01730352 Oct 2008 → May 2011 Helicobacter pylori infectious disease, autoimmune thrombocytopenic purpura Federal University of São Paulo Completed No outcome recorded
Phase 2/3 NCT00321178 May 2006 → Jan 2008 Buruli ulcer disease University Medical Center Groningen Completed No outcome recorded
Phase 2/3 NCT00403364 Jul 2003 → Feb 2006 Helicobacter pylori infectious disease IRCCS Azienda Ospedaliero-Universitaria di Bologna Completed No outcome recorded
Phase 336 trials
Phase 3 NCT06572761 Sep 2026 → May 2030 expected cervical incompetence Assistance Publique - Hôpitaux de Paris Not yet recruiting No outcome recorded
Phase 3 NCT07104318 Jul 2026 → Jun 2029 expected Helicobacter pylori infectious disease VA Office of Research and Development Not yet recruiting No outcome recorded
Phase 3 NCT06576882 Jun → Nov 2024 Helicobacter pylori infectious disease, gastritis Alexandria University Completed No outcome recorded
Phase 3 NCT04616924 Dec 2020 → Aug 2023 Mycobacterium avium complex disease, bronchiectasis RedHill Biopharma Limited Terminated No outcome recorded
Phase 3 NCT04107194 Jan 2020 → Feb 2021 Helicobacter pylori infectious disease University of Bari Unknown No outcome recorded
Phase 3 NCT04167670 Dec 2019 → Mar 2021 Helicobacter pylori infectious disease Phathom Pharmaceuticals, Inc. Completed No outcome recorded
Phase 3 NCT03779074 Sep 2018 → Dec 2021 Helicobacter pylori infectious disease Kaohsiung Veterans General Hospital. Completed No outcome recorded
Phase 3 NCT03491995 Apr 2018 → Apr 2023 Helicobacter pylori infectious disease Tanta University Unknown No outcome recorded
Phase 3 NCT04287660 Oct 2017 → Jan 2023 plasma cell myeloma The First Affiliated Hospital of Soochow University Unknown No outcome recorded
Phase 3 NCT03177629 May 2017 → Jun 2020 Helicobacter pylori infectious disease, autoimmune thrombocytopenic purpura Seoul National University Hospital Unknown No outcome recorded
Phase 477 trials
Phase 4 NCT07115173 Dec 2025 → Jun 2027 expected Helicobacter pylori infectious disease Samsung Medical Center Not yet recruiting No outcome recorded
Phase 4 NCT07040839 Jul 2025 → Feb 2026 overdue Helicobacter pylori infectious disease Rehman Medical Institute - RMI Not yet recruiting No outcome recorded
Phase 4 NCT06396078 Jul 2024 → Dec 2026 expected preterm premature rupture of the membranes Ohio State University Recruiting No outcome recorded
Phase 4 NCT07312721 Jan → Dec 2024 Helicobacter pylori infectious disease, chronic gastritis, peptic ulcer disease Azfar Farogh Completed No outcome recorded
Phase 4 NCT06168214 Sep 2023 → Nov 2024 overdue Xijing Hospital of Digestive Diseases Recruiting No outcome recorded
Phase 4 NCT05718609 Mar 2023 → Mar 2024 Helicobacter pylori infectious disease Second Affiliated Hospital, School of Medicine, Zhejiang University Unknown No outcome recorded
Phase 4 NCT07224035 Oct 2022 → Nov 2027 expected Helicobacter pylori infectious disease, gastric cancer, gastritis University of Miami Active not recruiting No outcome recorded
Phase 4 NCT06050824 Jul 2022 → Jul 2023 Helicobacter pylori infectious disease Helwan University Completed No outcome recorded
Phase 4 NCT05332444 Apr 2022 → Dec 2026 expected Helicobacter pylori infectious disease National Taiwan University Hospital Recruiting No outcome recorded
Phase 4 NCT05250050 Mar → Dec 2022 Helicobacter pylori infectious disease Shanghai Zhongshan Hospital Unknown No outcome recorded
Phase not applicable39 trials
NCT07533422 May → Dec 2026 expected Helicobacter pylori infectious disease Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting No outcome recorded
NCT07439445 Apr 2026 → Feb 2027 expected Helicobacter pylori infectious disease Peking University First Hospital Recruiting No outcome recorded
NCT07010744 Jul 2025 → Jun 2026 overdue dyspepsia Akil Al Islam Enrolling by invitation No outcome recorded
NCT05549115 Sep 2022 → Feb 2024 Helicobacter pylori infectious disease Liaocheng People's Hospital Unknown No outcome recorded
NCT05926804 Aug 2022 → Oct 2026 expected Helicobacter pylori infectious disease Miguel O'Ryan Gallardo Recruiting No outcome recorded
NCT05455372 Jul 2022 → Sep 2023 Helicobacter pylori infectious disease Second Affiliated Hospital of Xi'an Jiaotong University Unknown No outcome recorded
NCT05449028 May 2022 → Dec 2023 Helicobacter pylori infectious disease Unidade Local de Saúde de Coimbra, EPE Unknown No outcome recorded
NCT05226819 Feb → Sep 2022 Helicobacter pylori infectious disease Second Affiliated Hospital of Xi'an Jiaotong University Unknown No outcome recorded
NCT05133193 Nov 2021 → Jun 2022 Helicobacter pylori infectious disease Shandong University Unknown No outcome recorded
NCT05126121 Nov 2021 → Jun 2022 Helicobacter pylori infectious disease Xiuli Zuo Unknown No outcome recorded
Also used as a comparator or background therapy in 199 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 02 trials
Phase 0 NCT02019875 Comparator Jun 2014 → Dec 2020 calcium metabolic disease University of Washington Completed No outcome recorded
Phase 0 NCT02099240 Comparator Mar 2014 → Nov 2018 osteomyelitis University of Louisville Terminated No outcome recorded
Phase 113 trials
Phase 1 NCT07294846 Background Sep → Dec 2025 Jiangsu Sinorda Biomedicine Co., Ltd Completed No outcome recorded
Phase 1 NCT05716854 Comparator Mar → Jun 2023 Food and Drug Administration (FDA) Completed No outcome recorded
Phase 1 NCT03043989 Comparator Mar 2017 → Jul 2019 prostate cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Terminated No outcome recorded
Phase 1 NCT02998437 Comparator Dec 2016 → Jan 2017 Il-Yang Pharm. Co., Ltd. Completed No outcome recorded
Phase 1 NCT03011463 Comparator Nov 2016 → Mar 2017 Dr. R. Pfleger Chemische Fabrik GmbH Completed No outcome recorded
Phase 1/24 trials
Phase 1/2 NCT06823791 Comparator Aug 2022 → Jul 2024 Helicobacter pylori infectious disease Liaocheng People's Hospital Completed No outcome recorded
Phase 1/2 NCT03440112 Comparator Jan 2018 → Dec 2021 Parkinson disease Nicolaas Bohnen, MD, PhD Completed No outcome recorded
Phase 1/2 NCT02343042 Background Oct 2015 → Apr 2027 expected plasma cell myeloma Karyopharm Therapeutics Inc Recruiting No outcome recorded
Phase 1/2 NCT02803216 Background Jan 2013 → Dec 2015 Helicobacter pylori infectious disease Xiyuan Hospital of China Academy of Chinese Medical Sciences Completed No outcome recorded
Phase 213 trials
Phase 2 NCT07293910 Comparator Feb → Dec 2026 expected Helicobacter pylori infectious disease Tanta University Recruiting No outcome recorded
Phase 2 NCT06585020 Comparator Oct 2024 → Aug 2026 overdue Mycobacterium xenopi infection, lung disorder Centre Hospitalier Universitaire, Amiens Recruiting No outcome recorded
Phase 2 NCT06973889 Background Dec 2023 → Dec 2024 Helicobacter pylori infectious disease, digestive system disorder Mashhad University of Medical Sciences Completed No outcome recorded
Phase 2 NCT05957432 Comparator Aug 2023 → Oct 2025 overdue Helicobacter pylori infectious disease Ain Shams University Active not recruiting No outcome recorded
Phase 2 NCT05933031 Comparator Feb 2023 → Dec 2024 Helicobacter pylori infectious disease HK inno.N Corporation Unknown No outcome recorded
Phase 2/36 trials
Phase 2/3 NCT06591494 Comparator Sep 2024 → Sep 2025 overdue Helicobacter pylori infectious disease Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting No outcome recorded
Phase 2/3 NCT05861687 Background Aug → Dec 2021 Helicobacter pylori infectious disease Finni Kollins Completed No outcome recorded
Phase 2/3 NCT04630145 Background Jan 2021 → Nov 2024 Mycobacterium avium complex disease Janssen Pharmaceutical K.K. Completed No outcome recorded
Phase 2/3 NCT03132714 Comparator Mar 2015 → Oct 2016 periodontitis, aggressive São Paulo State University Completed No outcome recorded
Phase 2/3 NCT01627665 Comparator Oct 2011 → Jun 2014 Assistance Publique - Hôpitaux de Paris Completed No outcome recorded
Phase 347 trials
Phase 3 NCT07606833 Background Jun 2026 → Feb 2027 expected Helicobacter pylori infectious disease Xuanzhu Biopharmaceutical Co., Ltd. Not yet recruiting No outcome recorded
Phase 3 NCT07275827 Comparator Feb → Apr 2026 overdue Helicobacter pylori infectious disease Tanta University Not yet recruiting No outcome recorded
Phase 3 NCT06964334 Comparator Jun 2025 → Jun 2026 overdue Helicobacter pylori infectious disease Assiut University Not yet recruiting No outcome recorded
Phase 3 NCT07107477 Comparator May 2025 → Sep 2027 expected preterm premature rupture of the membranes The Central and Eastern European Gynecologic Oncology Group Recruiting No outcome recorded
Phase 3 NCT06760065 Comparator Jan 2025 → Dec 2027 expected Helicobacter pylori infectious disease Sixth Affiliated Hospital, Sun Yat-sen University Not yet recruiting No outcome recorded
Phase 478 trials
Phase 4 NCT07405684 Comparator Feb 2026 → Dec 2027 expected Helicobacter pylori infectious disease Shanghai Zhongshan Hospital Not yet recruiting No outcome recorded
Phase 4 NCT07405697 Comparator Feb 2026 → Dec 2027 expected Helicobacter pylori infectious disease Shanghai Zhongshan Hospital Not yet recruiting No outcome recorded
Phase 4 NCT07021729 Comparator Dec 2025 → Mar 2026 overdue Helicobacter pylori infectious disease Rehman Medical Institute - RMI Not yet recruiting No outcome recorded
Phase 4 NCT06200779 Comparator Sep 2025 → Sep 2026 expected Helicobacter pylori infectious disease Manuel Coelho da Rocha Not yet recruiting No outcome recorded
Phase 4 NCT07068607 Comparator Apr → Oct 2025 overdue Helicobacter pylori infectious disease, dyspepsia, gastric cancer, gastritis +1 Yongquan Shi Recruiting No outcome recorded
Phase not applicable36 trials
NCT07585461 Comparator Apr 2026 → Dec 2028 expected AIDS-related disorder, Mycobacterium avium complex disease Shanghai Public Health Clinical Center Not yet recruiting No outcome recorded
NCT07179159 Comparator Sep 2025 → Aug 2026 overdue Helicobacter pylori infectious disease Yanqing Li Recruiting No outcome recorded
NCT07086937 Background Jan → Jun 2025 Helicobacter pylori infectious disease Muhammad Aamir Latif Completed No outcome recorded
NCT07148622 Comparator Oct 2024 → Aug 2025 preterm premature rupture of the membranes Yuzuncu Yil University Completed No outcome recorded
NCT06207786 Background Sep 2024 → May 2029 epidermal appendage tumor, skin cancer Mayo Clinic Withdrawn No outcome recorded

Press releases naming this drug 6 releases

DateIssuerRelease
2006-06-27 Teva Branded Pharmaceutical Products R&D, Inc. Teva Provides Generic Biaxin® Xl Update tevapharm.com
2006-06-22 Teva Branded Pharmaceutical Products R&D, Inc. Court of Appeals Rules in Favor of Teva on Biaxin® XL Preliminary Injunction tevapharm.com
2005-06-05 Teva Branded Pharmaceutical Products R&D, Inc. Teva Comments On Clarithromycin Er Preliminary Injunction tevapharm.com
2005-06-01 Teva Branded Pharmaceutical Products R&D, Inc. Teva Announces Approval Of Clarithromycin Tablets Usp, 250 Mg And 500 Mg tevapharm.com
2005-05-20 Teva Branded Pharmaceutical Products R&D, Inc. Teva Comments On Clarithromycin Er Tablet Litigation tevapharm.com
2005-05-18 Teva Branded Pharmaceutical Products R&D, Inc. Teva Announces Approval Of Clarithromycin Er Tablets tevapharm.com

Evidence & citations 50 cited values

Every value below carries the sentence it was read from. 460 sources stand behind the page.

FieldValueCited text
Known as Clarithromycin “Eligible patients were randomly assigned to receive intramuscular streptomycin (15 mg/kg once daily) and oral rifampicin (10 mg/kg once daily) for 8 weeks (8-week streptomycin...” PMID 20137805 Feb 2010
452

“Participants with positive results for infection received a standard 7-day triple therapy (esomeprazole 40 mg once daily, amoxicillin 1 g twice daily, and clarithromycin 500 mg...” PMID 16961802 Oct 2006

“Children up to 5 years: clarithromycin 15mg/kg, amoxicillin 50mg/kg, and/or furazolidone 7mg/kg Children above 8 years: doxycycline 4,4mg/kg if necessary Children able to...” NCT01730352

“14-day bismuth quadruple therapy (pantoprazole, bismuth subcitrate, tetracycline, and metronidazole for 14 days) or 14-day hybrid therapy (a 7-day dual therapy with...” PMID 28807915 Oct 2017

“Eligible patients were randomised to receive LAL: levofloxacin (750 mg once a day), amoxicillin (1000 mg twice a day) and lansoprazole (30 mg twice a day) for 7 days, or CAL:...” PMID 20427390 May 2010

“Sequential therapy comprised esomeprazole (40 mg) or tegoprazan (50 mg) plus amoxicillin (1000 mg) twice daily for the initial 5 days, followed by esomeprazole (40 mg) or...” PMID 39434634 Sep 2024

Clarithromycin is a macrolide antibiotic used to treat pharyngitis, tonsillitis, acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, pneumonia...” NCT01667692

“Based on the susceptibility results and penicillin-allergic test, a tailored 7-day triple or quadruple therapy regimen is prescribed, including Tegoprazan , Amoxicillin,...” NCT07405697

“a 7-day quadruple regimen with pantoprazole 40 mg twice daily, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily, and metronidazole 500 mg twice daily, followed by...” NCT02547038

“Group 1: (110) participants received reverse hybrid regimen in the form of clarithromycin 500mg bid, omeprazole 20 mg bid, amoxicillin 1gm bid, and metronidazole 500 mg tid for...” NCT04039412

“Treatment for H. pylori Patients with positive Urea Breath Test (positive for H. pylori infection) will be started on eradication therapy of H. pylori (oral esomeprazole 40mg...” NCT02112812

“sequential: lansoprazole 30mg bid+amoxicillin 100mg bid for first five day lansoprazole 30mg bid+clarithromycin 500mg bid+metronidazole 500mg for 5day conventional tripe...” NCT01418300

“12 grams of egg yolk powder containing about 2 grams of antibody twice a day for 2 weeks along with usual antibiotic treatment including OAC or omeprazole (40 mg/day),...” NCT06973889

“a dual regimen with rabeprazole 20 mg and amoxicillin 1 g b.i.d. for 7 days followed by a quadruple regimen with rabeprazole 20 mg, amoxicillin 1 g, clarithromycin 500 mg and...” NCT03779074

“H. pylori infected patients treated with 10 mg rabeprazole and 1 g amoxicillin, twice daily for 7 days, followed by 10 mg rabeprazole, 500 mg clarithromycin, and 500 mg...” NCT02776371

“patients will receive concomitant therapy comprising of pantoprazole (40 mg twice daily), amoxicillin (1 gm twice a day), clarithromycin (500 mg twice a day) and metronidazole...” NCT06050824

“Dose of two sensitive antibiotics are listed as follows : amoxicillin 1000mg bid, clarithromycin 500mg bid, tinidazole 500mg tid, levofloxacin 500mg qd, furazolidone 100mg bid,...” NCT03565484

“The control group will be treated with Omeprazole 20mg every 12 hours, Amoxicillin 1 gr every 12 hours, Clarithromycin 500 mg every 12 hours, Placebo identical to Bismuth...” NCT05664685

“(pantoprazole 40 mg + amoxicillin 1.0 g) bid for the first 5 days, subsequently (pantoprazole 40 mg + clarithromycin 500 mg + metronidazole 500 mg ) bid for the next 5 days :...” NCT02108184

“Patients with bacteriologically proven H pylori infection will be randomly allocated to either empirical usual treatment with PPI , amoxicillin 1g, clarithromycin 500 mg X 2...” NCT01168063

“Eradication group patients received oral omeprazole 20 mg, amoxicillin 1 g, and clarithromycin 500 mg twice daily for a week, whereas control group patients received no H...” PMID 29800546 May 2018

“The candidated drugs to be selected are:Cs-Cycloserine,Pto-Protionamide,Clr-Clarithromycin,PAS-sodium para-aminosalicylate,E-ethambutol,Bdq-Bedaquiline,Cfz-Clofazimine,Lzd-linezolid” NCT03830671

“esomeprazole 20 mg, amoxicillin 1 g, and clarithromycin 500 mg, each twice daily followed by gastric mucosal protective therapy with teprenone 50mg three times daily for 11 weeks” NCT01547559

“Rabeprazole quadruple therapy for 14 days (R14 group): Rabeprazole sodium 10 mg + Amoxicillin 1 g + Clarithromycin 500 mg + Colloidal pectin bismuth 200 mg, bid, for 14 days.” NCT07122024

“Bismuth potassium citrate:given for 14 days at a dose of bismuth potassium citrate 220 mg 0 BID,rabeprazole 10 mg BID, amoxicillin 1000 mg BID, and clarithromycin 500 mg BID” NCT04209933

“pantoprazole 40 mg, amoxicillin 1 g, clarithromycin 500 mg and metronidazole 500 mg for the first 7 days, followed by pantoprazole 40 mg, amoxicillin 1 g for another 5 days” NCT02359435

“Current guidelines recommend a macrolide-based triple therapy consisting of a macrolide (azithromycin or clarithromycin), ethambutol, and a rifamycin (typically rifabutin).” NCT07585461

“For oral antibiotics, the choices providers will be given include: Augmentin 500 mg every 12 hours, Cefuroxime 500 mg every 12 hours, Clarithromycin 500 mg every 6 hours” NCT03935828

“Two antibiotics based on antibiotic sensitivity of H.pylori culture, including amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline and furazolidone.” NCT02894268

“The triple regimen was defined as a combination of amoxicillin 1 gm twice a day, clarithromycin 500 mg twice a day and omeprazole is given in 40 mg twice a day dose.” NCT03968302

“esomeprazole 40 mg and amoxicillin 1 g twice daily for 7 days followed by esomeprazole 40 mg, clarithromycin 500 mg and metronidazole 500 mg twice daily for 7 days” NCT01085786

“rabeprazole 20mg bid + amoxicillin 1g bid treated for 5 days, then rabeprazole 20mg bid + amoxicillin 1g bid + clarithromycin 0.5g bid + metronidazole 0.5g bid” NCT01566643

“triple therapy:a 10-day course of a Lansoprazole (proton pump inhibitor )combined with amoxicillin (2 × 1 g daily) and clarithromycin (2 × 500 mg daily).(trio)” NCT03654781

Clarithromycin-sensitive strains: Esomeprazole 20 mg, Bismuth Potassium Citrate 220 mg, Amoxicillin 1 g, and Clarithromycin 500 mg, twice daily for 14 days.” NCT06760065

“rabeprazole 20mg b.i.d + amoxicillin 1000mg b.i.d x 5 days + rabeprazole 20mg b.i.d + clarithromycin 500mg b.i.d + metronidazole 500mg b.i.d x last 5 days.” NCT01573975

“Ilaprazole -based quadruple therapy for 14 days: Ilaprazole 5mg bid, Bismuth Potassium Citrate 220mg bid, amoxicillin 1000mg bid, clarithromycin 500mg bid” NCT02835560

“In this arm, they are treated with vonoprazan 20 mg bid, amoxicillin 750 mg bid and clarithromycin 200 mg bid for 1 week for the eradication of H. pylori.” NCT02761005

“Amoxicillin 1g + Clarithromycin 500 mg and Tegoprazan 50 mg vs Amoxicillin 1g + Clarithromycin 500 mg and Esomeprazole 40 mg Twice a Day for 14 Days” NCT06318104

“Patients sensitive to clarithromycin are assigned to the Clarithromycin Group (receiving a regimen of vonoprazan, amoxicillin, and clarithromycin)” NCT07533422

“Group 1 will receive clarithromycin 500 mg twice daily (bid), amoxicillin 1 g bid, and lansoprazole 30 mg bid (Pylopac®, Medix SA de CV, Mexico);” NCT02726269

“pantoprazole 40 mg twice daily, clarithromycin 500 mg twice daily, amoxicillin 1 g twice daily and metronidazole 500 mg twice daily for 7 days” NCT01769365

“with dexlansoprazole MR 60 mg once daily, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily, and metronidazole 500 mg twice daily” NCT02646332

“Subjects will receive the rabeprazole 10mg, moxycillin 1.0g, clarithromycin 500mg and Jinghua Weikang Capsule 240mg twice daily for 14 days.” NCT05320133

“CLA (clarithromycin) at the same dose and on the same days as the patient's lenalidomide-containing treatment (it varies for each subject).” NCT02188368

“priority antibiotic selection was as follow: Amoxicillin \> Clarithromycin \> Levofloxacin \>Tetracycline \> Furazolidone \> Metronidazole.” NCT02689583

“Patient receive Omeprazole plus amoxicillin during 5 days and then omeprazole plus clarithromycin and metronidazole during another 5 days” NCT02395458

“Rabeprazole 20mg twice daily, bismuth potassium citrate 220mg twice daily, Amoxycillin 1g twice daily, clarithromycin 500mg twice daily.” NCT05364619

“including Tegoprazan , Amoxicillin, Clarithromycin, Levofloxacin, Bismuth Potassium Citrate, Metronidazole, Doxycycline or Minocycline.” NCT07405684

“Concomitant for 10 days, including 40 mg of esomeprazole bid, amoxicillin 1g bid, clarithromycin 500mg bid and metronidazole 500mg bid.” NCT03592069

“Initial H pylori eradication with triple therapy (rabeprazole 20 mg qd, amoxicillin 1gm bid, clarithromycin 500 mg bid) for two weeks.” NCT02934152

“pantoprazole 40 mg twice daily, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily, and metronidazole 500 mg twice daily” NCT04566211

“PPI quadruple therapy refers to ilaprazole 5mg + amoxicillin 1000mg + clarithromycin 500mg + colloidal bismuth tartrate 220mg bid.” NCT05455372

“Antibiotics are selected from Amoxicillin, Tetracycline, Furazolidone, Levofloxacin, Clarithromycin, Tinidazole, Metronidazole.” NCT05133193

“10 days standard triple therapy (Omeprazole 0.8-1.0mg/kg.d,bid, Amoxicillin 30-50mg/kg.d bid, Clarithromycin 15-20mg/kg.d bid)” NCT02635191

“1 g Amoxicillin, 500 mg clarithromycin and 600 mg bismuth potassium citrate/bismuth tripotassium dicitrate, twice daily (BID).” NCT03050307

“1 g Amoxicillin, 500 mg clarithromycin and 600 mg bismuth potassium citrate/bismuth tripotassium dicitrate, twice daily (BID).” NCT03050359

clarithromycin triple therapy: include rabeprazole 20mg bid, amoxicillin 1 g bid, and clarithromycin 500 mg bid, for 14 days” NCT05332444

“D1-D7: (lansoprazole 30mg + amoxicillin 1gm) bid D8-D14: (lansoprazole 30mg + clarithromycin 500mg + metronidazole 500mg) bi” NCT01042184

“esomeprazole (20 mg, twice daily), clarithromycin (500 mg, twice daily), and amoxicillin (1.0 g, twice daily) for 14 days” NCT05549115

“10-day HD-PPI-TT (60 mg lansoprazole/500 mg clarithromycin/1 g amoxicillin, each administered twice daily for 10 days)” PMID 29804294 Jun 2018

“Lansoprazole 30mg, 2 times a day + Clarithromycin 500mg, 2 times a day + Amoxicillin 1000mg, 2 times a day for 7 days” NCT02557932

“followed by rabeprazole (20 mg), clarithromycin (500 mg) and tinidazole (500 mg) twice daily for the remaining 5 days” PMID 12641522 Mar 2003

“10-days rabeprazole 20mg b.i.d + clarithromycin 500mg b.i.d + amoxicillin 1000mg b.i.d + N-acetyl-cystein 600mg b.i.d” NCT01572597

“Rabeprazole tablets 10mg 2/day+colloidal pectin bismuth 200mg 2/day+Amoxicillin 1g 2/day+Clarithromycin 500mg 2/day” NCT06004401

“second line immune-modulator regimens (CAMC, clarithromycin (CAM) and low-dose cyclophosphamide) will be prescribed” NCT07144657

“Esomeprazole 40mg bid + amoxicillin 1g 12/12h + clarithromycin 500mg 12/12h + metronidazole 500mg 8/8h, for 14 days” NCT05449028

“Arm 1: The first group will receive (amoxicillin 1g/12 hrs, Clarithromycin 500 mg/12hrs, esomeprazole 40mg/12hrs)” NCT05035186

“Proton pump inhibitor (eg, omeprazole 20 mg BID), Clarithromycin 500 mg BID, metronidazole 500 mg BID for 14 days” NCT03347513

“H. pylori eradication therapy comprising esomeprazole, amoxicillin,clarithromycin and colloidal bismuth pectin.” NCT02933229

“Standard triple therapy will be based on Esomeprazole 20 mg BD, Clarithromycin 500mg BD and Amoxicillin 1gm BD.” NCT07010744

“Naïve patients will receive classic triple therapy (amoxicillin, clarithromycin and lansoprazole) for 14 days” NCT05184491

“dexlansoprazole MR 60 mg once daily+clarithromycin 500 mg twice daily+ amoxicillin 1 g twice daily for 7 days” NCT02541786

“Omeprazole 20 mg or Rabeprazole 10 mg bid + clarithromycin 500 mg and amoxicillin 1,000 mg bid for 7 days” NCT01002443

“to anti-MAP RHB-104 (clarithromycin 95 mg, rifabutin 45 mg, and clofazimine 10 mg per capsule) (n = 166)” PMID 39199994 Jul 2024

“D8-D14: (esomeprazole 40mg qid + clarithromycin 500mg bid + metronidazole 500mg bid) for another 7 days” NCT03156855

“ten days of standard triple region (20mg omeprazole 20mg, 1.0 amoxicillin, 0.5 clarithromycin, Bid).” NCT02803216

“Triple therapy for H. pylori infection (Esomeprazole, Amoxicillin, and Clarithromycin) for two weeks” NCT05297695

“rabeprazole 20 mg,amoxicillin 1000 mg,metronidazole 500 mg,clarithromycin 500 mg, bid for 10 days” NCT01265069

“oral quinolone (ciprofloxacin or levofloxacin) or oral macrolide (azithromycin or clarithromycin)” NCT03220074

“rabeprazole 20mg B.I.D, amoxicillin 1000mg B.I.D, and clarithromycin 500mg B.I.D for seven days.” NCT04061447

“Lansoprazole 30 mg, amoxicillin 1,000 mg, and clarithromycin 500 mg, all twice a day for 1 week.” NCT01678027

“omeprazole 2x1) + clarithromycin 2x500 mg + amoxicilline 2x1000 mg + Bismuth Subsalicylate 2x1” NCT03757650

“omeprazole, amoxicillin trihydrate, and clarithromycin, or omeprazole plus placebo for 10 days” PMID 22123802 Nov 2011

“Esomeprazole 20 mg BID Bismuth pectin 200 mg BID Amoxicillin 1 g BID Clarithromycin 500 mg BID” NCT06591494

“Omeprazole, 20mg, amoxicillin, 1000mg, and clarithromycin, 500mg, all twice a day for 2 weeks.” NCT01133951

Clarithromycin 500-1000 mg, plus ethambutol hydrochloride (HCl) 15 mg/kg orally once daily or” NCT04553406

“Oral twice-daily doses of rabeprazole (20 mg), amoxicillin (1 g) and clarithromycin (500 mg)” NCT01967329

“In the absence of 23S rRNA mutation, clarithromycin based sequential therapy will be given.” NCT03556254

“treatment: H. pylori eradication (pantoprazole, amoxicillin, clarithromycin, metronidazole)” NCT03177629

“dual oral antibiotic therapy with Ofloxacin 400mg and Clarithromycin 500mg will be used” NCT07454772

Clarithromycin (Klaricid®, Abbot Korea Co. Ltd., Seoul, Korea) 500 mg, bid, for 7 days” NCT02090738

“vonoprazan 20mg+amoxicillin 1000 mg + clarithromycin 500 mg twice daily for seven days” NCT05371249

“rabeprazole 20 mg , metronidazole 500 mg, clarithromycin 500 mg, bid for next 5 days” NCT01163435

“Standard 14 day, 3 drug regimen: lansoprazole, amoxicillin, clarithromycin (PACx14)” NCT01061437

“esomeprazole 40 mg, amoxicillin 1 g, clarithromycin 500 mg twice a day for 10 days” NCT04006340

“Omeprazole 40 mg BID, Amoxicillin 1 g BID, Clarithromycin 500 mg BID for 14 days.” NCT07312721

“Each capsule contains clarithromycin 158.3mg; rifabutin 40mg; clofazimine 13.3mg.” NCT04616924

clarithromycin (Klaricid®, Abbot Korea Co. Ltd., Seoul, Korea) 500 mg twice daily” NCT02368470

“Scheme 1 Amoxicillin 1000 mg, 2 times/d; Clarithromycin 500mg, 2 times per day” NCT04660123

“D8-D14: (esomeprazole + clarithromycin + metronidazole bid) for another 7 days” NCT03722433

“with amoxicillin 1,000 mg plus clarithromycin 500 mg twice daily for 10 days” PMID 40462641 Jun 2025

“after a 5-day treatment with 500 mg b.i.d. clarithromycin, a P-gp inhibitor” PMID 31157746 Nov 2019

“Amoxycillin 1gm twice a day (BD) Clarithromycin 500mg BD Omeprazole 20mg BD” NCT02108704

“Triple therapy of proton pump inhibitors, clarithromycin and metronidazole.” NCT04512898

“Doxycycline, Paramomycin, Clarithromycin, Clindamycin, Dapsone, Miltefosine” NCT02366884

“Omeprazole 30mg twice Clarithromycin 500mg twice Amoxicillin 1000mg twice” NCT01938534

“esomeprazole 20mg b.d., amoxicillin 1g b.d. and clarithromycin 500mg b.d.” NCT01306786

“amoxicillin/clavulanate, clarithromycin, azithromycin and thioacetazone” NCT03237182

“rabeprazole 20mg, amoxicillin 1g and clarithromycin 500mg twice-daily” NCT03108287

“Tegoprazan 50 mg/Clarithromycin/ Amoxicillin BID peroral, 14 days” NCT05933031

Clarithromycin 500mg po every 12h for 7-10 days or till delivery.” NCT07107477

“Standard treatment = Rifampicin, ethambutol and clarithromycinNCT06585020

“95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine” NCT01717664

“lansoprazole 30mg + clarithromycin 500mg + amoxicillin 1gm” NCT01906879

Clarithromycin 33-50kg 500 mg daily, \>50kg 1000 mg daily” NCT02120638

“Lansoprazole, Amoxicillin 1000 mg, Clarithromycin 500 mg” NCT00926809

Clarithromycin 500 mg (1 tablet twice daily for 14 days)” NCT07224035

clarithromycin (500 mg, bid) from day 6 to day 10” NCT00656968

Clarithromycin ('Makcin') 500 mg bid for 14 days” NCT03572777

clarithromycin 500mg twice daily for 14 days” NCT03321773

Clarithromycin 500 mg tablets twice daily” NCT06101420

clarithromycin 500mg - i PO BID x10 days” NCT00664209

clarithromycin 500mg bid for last 5 days” NCT01760824

Clarithromycin 500 mg orally twice daily” NCT01723059

“Omeprazole, amoxycillin, clarithromycinNCT03491995

Clarithromycin 20mg/kg/day for 2 weeks” NCT05879237

Clarithromycin 500 mg 2x1, for 14 days” NCT03997279

Clarithromycin 500mg 1tab twice daily” NCT05786807

“Omeprazole+Amoxicillin+ClarithromycinNCT03365609

Clarithromycin 500 mg bid for 10 days” NCT02047994

“IV clarithromycin may be substituted” NCT02735707

clarithromycin-XL 500mg twice daily” NCT04713670

clarithromycin (500 mg x 2 per day)” NCT04769583

Clarithromycin 500mg, PO, BID, 1wk” NCT02759029

clarithromycin 500mg twice daily” NCT05635942

Clarithromycin tablets 500mg” NCT07606833

“Azithromycin/clarithromycinNCT06207786

Clarithromycin (BIAXIN®)” NCT00538733

Clarithromycin 500mg bd” NCT02092506

clarithromycin 500 mg” NCT06572761

clarithromycin 500mg” NCT02547025

Clarithromycin*” NCT02099240

NCT00197418

NCT05991401

NCT02387203

NCT00000971

NCT00297674

NCT02248428

NCT06294600

NCT06227832

NCT00001047

NCT03428568

NCT05380245

NCT01559935

NCT01146600

NCT01516606

NCT00269386

NCT02693574

NCT05345210

NCT05718609

NCT03065868

NCT03440112

NCT06823791

NCT02633930

NCT02829983

NCT00336505

NCT01401179

NCT01887249

NCT04445948

NCT04843579

NCT02343289

NCT04901663

NCT02422706

NCT05633147

NCT02275988

NCT04132479

NCT00001039

NCT03124420

NCT01593592

NCT01659437

NCT00336544

NCT00840411

NCT00002331

NCT02542657

NCT00818610

NCT03555526

NCT07068607

NCT07021729

NCT02373280

NCT02648659

NCT00182663

NCT06751121

NCT03009396

NCT02935010

NCT04901117

NCT04449185

NCT05014334

NCT07086937

NCT00149084

NCT06514274

NCT05237115

NCT06523764

NCT00001023

NCT02171585

NCT01667575

NCT01219764

NCT00598897

NCT05957432

NCT00621504

NCT01159574

NCT02251769

NCT07341100

NCT04622891

NCT02388581

NCT01505127

NCT03414918

NCT02159976

NCT05845567

NCT04621487

NCT05915871

NCT00327132

NCT00645086

NCT04063189

NCT06396078

NCT05194046

NCT03571230

NCT02852083

NCT00840216

NCT00121550

NCT00354952

NCT03173053

NCT03829150

NCT04302324

NCT03220542

NCT05137600

NCT06168214

NCT02573935

NCT03362281

NCT07115173

NCT01207739

NCT00643227

NCT01575899

NCT03130452

NCT01602874

NCT00205634

NCT00707330

NCT00513552

NCT01454076

NCT01298336

NCT00538733

NCT03142776

NCT06804096

NCT02286635

NCT06964334

NCT01385683

NCT02575144

NCT04090021

NCT07148622

NCT00002194

NCT03031483

NCT04026958

NCT05191888

NCT06156085

NCT01506986

NCT01922765

NCT06162949

NCT00367913

NCT04198363

NCT07439445

NCT05196945

NCT05716854

NCT05226819

NCT01521364

NCT05049902

NCT00151203

NCT03139253

NCT01326611

NCT00004689

NCT02827942

NCT00772837

NCT01273441

NCT00648830

NCT02466919

NCT05410223

NCT02624440

NCT02416570

NCT00355602

NCT00475527

NCT02249546

NCT00669955

NCT00003617

NCT04558502

NCT01851954

NCT06576882

NCT03800550

NCT01460407

NCT01836198

NCT02986451

NCT04415983

NCT02019875

NCT03824847

NCT04551963

NCT02182492

NCT05469126

NCT05342532

NCT00002192

NCT03688828

NCT01745588

NCT01374217

NCT00002101

NCT00836706

NCT01607918

NCT05857163

NCT06837259

NCT02516696

NCT00000644

NCT00717561

NCT03498456

NCT03208426

NCT01279252

NCT03366974

NCT02998437

NCT00648960

NCT04697186

NCT01652118

NCT02892409

NCT02969928

NCT03142620

NCT00835692

NCT04359966

NCT05126121

NCT03238612

NCT04853875

NCT03132714

NCT00154440

NCT00002336

NCT05169554

NCT00006219

NCT00984061

NCT00003151

NCT04167670

NCT02975037

NCT07275827

NCT06200779

NCT03317223

NCT01289756

NCT00318708

NCT05614934

NCT01503606

NCT00445692

NCT00775372

NCT00467571

NCT01421706

NCT07294846

NCT00403364

NCT04107194

NCT03236987

NCT06551623

NCT03172676

NCT00644553

NCT03516669

NCT05061732

NCT06959368

NCT05250050

NCT04398004

NCT04721704

NCT03650543

NCT02407119

NCT02359721

NCT00000794

NCT05023577

NCT07211880

NCT02197884

NCT03134378

NCT03413020

NCT01223690

NCT04444011

NCT00001030

NCT00368342

NCT02117648

NCT06349486

NCT04617613

NCT00881179

NCT00990405

NCT04287660

NCT04525664

NCT03487562

NCT07179159

NCT05965570

NCT03709355

NCT04016051

NCT05419674

NCT05861687

NCT07485010

NCT02988089

NCT02361619

NCT01464060

NCT04658277

NCT06005714

NCT07040839

NCT04070495

NCT03345992

NCT00001058

NCT07040787

NCT02732249

NCT00002140

NCT04630145

NCT04753437

NCT04951713

NCT00002682

NCT04697641

NCT00648128

NCT00381147

NCT00914888

NCT05926804

NCT04310930

NCT03708848

NCT01481844

NCT02080780

NCT03165253

NCT07293910

NCT04101708

NCT05647278

NCT01921647

NCT02343042

NCT02175901

NCT00600769

NCT05259007

NCT02774902

NCT06315478

NCT05417997

NCT03043989

NCT02052336

NCT00000826

NCT03658746

NCT06510010

NCT03011463

NCT00719420

NCT02807051

NCT07696091

NCT02296021

NCT05742568

NCT04724044

NCT06250634

NCT00881738

NCT04652284

NCT02912234

NCT03716622

NCT00983034

NCT03021590

NCT06603688

NCT05189444

NCT07104318

Known as 6-o-methylerythromycin ChEMBL registry synonym — accepted as the source's own label CHEMBL1741
Known as A-56268 ChEMBL registry synonym — accepted as the source's own label CHEMBL1741
Known as ABBOTT-56268 ChEMBL registry synonym — accepted as the source's own label CHEMBL1741
Known as Biaxin “The study was conducted as an open label, balanced, randomised, two-treatment, four-period, two-sequence, single-dose, crossover fully replicated, bioavailability study on...” NCT00775372
7

“Clarithromycin 500 mg Tablet (test) dosed in first period followed by Biaxin® 500 mg Tablet (reference) dosed in second period” NCT00835692

“Clarithromycin (Biaxin®) will be given orally at a dose of 500 mg twice a day beginning on day 2 of cycle 1.” NCT00151203

Biaxin (Clarithromycin) 250 mg Tablets (Abbott Laboratories, Inc, USA)” NCT00881179

Biaxin® (Clarithromycin) 250 mg tablet” NCT00648830

“Clarithromycin (BIAXIN®) 500 mg Bid” NCT02251769

“Clarithromycin (BIAXIN®)” NCT00538733

Biaxin ( clarithromycin)” NCT00205634

Known as Biaxin Filmtabs “Biaxin®, Biaxin® Filmtabs” NCT00648830
Known as Biaxin xl ChEMBL registry synonym — accepted as the source's own label CHEMBL1741
Known as Biaxin xl pac ChEMBL registry synonym — accepted as the source's own label CHEMBL1741
Known as CAM “Most patients who have failed in the eradication of H. pylori infection by triple therapy with a PPI, amoxicillin (AMPC) and clarithromycin (CAM) at standard doses have...” NCT00197418
2

“The purpose of the study is to evaluate the efficacy of bedaquiline (BDQ) compared with rifamycin when administered as part of a treatment regimen with clarithromycin (CAM) and...” NCT04630145

“second line immune-modulator regimens (CAMC, clarithromycin (CAM) and low-dose cyclophosphamide) will be prescribed” NCT07144657

Known as CASnr 81103-11-9 CASnr 81103-11-9NCT01207739
Known as CLA CLA (clarithromycin) at the same dose and on the same days as the patient's lenalidomide-containing treatment (it varies for each subject).” NCT02188368
2

“WHO-recommended treatment requires 8-weeks of daily rifampicin (RIF) and clarithromycin (CLA) with wound care.” PMID 38573915 Apr 2024

“In Group A: Amoxicillin AMO + Clarithromycin CLA + Proton pump inhibitor PPI will be given to children” NCT04721704

Known as Clarie xl ChEMBL registry synonym — accepted as the source's own label CHEMBL1741
Known as Clarithro Clarithro -pantoprazole- Metronidazole - Amoxicyllin” NCT06050824
Known as Clarithromycin component of prevpac ChEMBL registry synonym — accepted as the source's own label CHEMBL1741
Known as Clarithromycin extended release ChEMBL registry synonym — accepted as the source's own label CHEMBL1741
Known as Clarithromycin identity ChEMBL registry synonym — accepted as the source's own label CHEMBL1741
Known as clarithromycin or Klacid clarithromycin or KlacidNCT00467571
Known as Clarithromycin S/R (Klaricid XL) Clarithromycin S/R (Klaricid XL)NCT00269386
Known as Clarithromycin XL Clarithromycin XL administered once daily on Days 4 through 9 as 2 x 500 mg tablets, 1000 mg per day, for a total of 6000 mg” NCT02080780
Known as Clarithromycin, 250/500mg (Pharmachemie) RVG 029081/029082 Clarithromycin, 250/500mg (Pharmachemie) RVG 029081/029082NCT01521364
Known as Clarithromycin: Klacid Clarithromycin: KlacidNCT01219764
Known as Clarithromycine ChEMBL registry synonym — accepted as the source's own label CHEMBL1741
Known as Clarithromycine Mylan, RVG 32619 Clarithromycine Mylan, RVG 32619NCT01207739
Known as Claritromicina ChEMBL registry synonym — accepted as the source's own label CHEMBL1741
Known as Clarosip ChEMBL registry synonym — accepted as the source's own label CHEMBL1741